From: Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
Variable - 1st line | n (%), median (range) |
---|---|
Initial management at diagnosis of ULMS | |
Surgical resection alone | 3 (19%) |
Surgical resection and BSO | 13 (81%) |
Number of prior chemotherapy regimens | |
0 | 12 (75%) |
1 | 2 (12.5%) |
2 | 2 (12.5%) |
Prior exogenous estrogens | |
Tamoxifen | 3 (19%) , 60 months |
HRT | 4 (25%), 48 months (24–96) |
Prior pelvic radiotherapy | 1 (6%) |
Median interval between diagnosis (surgery) and letrozole initiation | 37 months (2–308) |